Akari Therapeutics, Plc (AKTX)
NASDAQ: AKTX · Real-Time Price · USD
1.320
+0.060 (4.76%)
At close: May 12, 2025, 4:00 PM
1.385
+0.065 (4.92%)
After-hours: May 12, 2025, 4:05 PM EDT
Akari Therapeutics, Market Cap
Akari Therapeutics, has a market cap or net worth of $38.12 million as of May 12, 2025. Its market cap has increased by 304.24% in one year.
Market Cap
38.12M
Enterprise Value
41.38M
1-Year Change
304.24%
Ranking
Category
Stock Price
$1.32
Market Cap Chart
Since September 28, 2015, Akari Therapeutics,'s market cap has decreased from $291.48M to $38.12M, a decrease of -86.92%. That is a compound annual growth rate of -19.06%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |